Drug intelligence / Profile preview

fentonium

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Intravenous
01

Overview

Fentonium is a synthetic small molecule drug classified as an atropine derivative and a quaternary analog of hyoscyamine. It acts primarily as an anticholinergic, antispasmodic, and anti-ulcerogenic agent. Fentonium functions by blocking muscarinic acetylcholine receptors (antimuscarinic action), thereby inhibiting parasympathetic nerve impulses in smooth muscle, secretory glands, and the central nervous system. Additionally, it is reported to act as an allosteric blocker of α12βγε nicotinic receptors and can increase spontaneous acetylcholine release at the motor endplate without depolarizing muscle or inhibiting cholinesterase activity. Fentonium has been investigated for its effects on gastrointestinal disorders and opioid withdrawal symptoms in animal models[1][2][5][8][10].

Other names
fentonium bromide
02

Targets

mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on fentonium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fentonium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call